Weight gain during menopause is not caused by women eating more. It is caused by a metabolic shift with concrete biological causes, and the standard advice to eat less and exercise more is not always the answer.
On average, women gain two to five kilograms during the transition into menopause. Most of it accumulates around the belly, regardless of what they eat or how much they exercise.
They are told that this is normal. They are told to eat less, exercise more, and accept that their bodies are changing. This advice fails most women who follow it. Not because they lack discipline, but because it addresses the wrong problem.
Weight gain during menopause is driven by specific biological mechanisms that cannot be reversed by reducing calories. Understanding these mechanisms is the only way to effectively address them.
What estrogen does to fat distribution
Estrogen directly determines where fat is stored in the female body. At sufficient levels, it directs fat storage preferentially to peripheral areas such as the hips and thighs.
As estrogen levels drop during perimenopause and fall sharply at menopause, this distribution changes. Instead, the body begins to store visceral fat, which is fat around the internal organs in the abdominal cavity.
Visceral fat differs not only visually from fat in other areas. It is metabolically active tissue: It produces pro-inflammatory messengers, disrupts hormonal signaling pathways, and independently worsens insulin resistance.
This creates a cycle that cannot be broken by dietary changes alone. Because they address the inflow, not the mechanism that drives storage.
The insulin resistance no one explains
The most important metabolic change behind weight gain during menopause is insulin resistance. And it is almost never clearly explained to the affected women.
Insulin is the hormone that signals cells to take up glucose from the blood and convert it into energy. When cells become insensitive to this signal, glucose is no longer used efficiently, but is instead directed into fat storage, especially visceral fat.
This is primarily not a consequence of too much sugar. It is the consequence of cells that can no longer efficiently produce energy. And this problem has its roots in the decline of NAD⁺.
NAD⁺ is needed for the signaling pathways through which insulin controls glucose uptake in muscle cells. As NAD⁺ levels drop in your 30s and 40s, these signaling pathways respond less effectively. This creates insulin resistance, which is exacerbated by the hormonal changes of perimenopause.
The result is a body that stores fat more easily, burns energy less efficiently, and responds increasingly poorly to dietary changes because the underlying metabolic mechanism remains untouched.
NMN supplementation significantly increased insulin sensitivity in the muscles of postmenopausal women with prediabetes. This opens up possible approaches for age-related metabolic disorders that disproportionately affect women after menopause.
— Yoshino et al., 2021
What research on restoring NAD⁺ has found
In 2021, researchers at the Washington University School of Medicine published a randomized, placebo-controlled, double-blind study in the journal Science. They studied postmenopausal women with prediabetes—that is, the group in which both the decline in NAD⁺ and insulin resistance are most advanced and best measurable.
After ten weeks of daily NMN intake, the participants showed significantly better insulin sensitivity in their muscles. In addition, the activity of genes involved in the structure and remodeling of muscle tissue increased.
This is the first human study to show: The restoration of NAD⁺ through NMN leads to measurable improvements in exactly that metabolic disorder that drives weight gain during and after menopause.
Another study from 2021, published in the Journal of the International Society of Sports Nutrition, found significantly improved oxygen utilization and endurance performance in amateur runners through NMN. Behind this is the same improvement in mitochondrial efficiency, which also determines how well the body burns energy at rest.
Mitochondrial function and metabolic rate are directly linked, and both decline with NAD⁺ levels. That is why research on active groups is also relevant for the metabolic health of women who are not athletes.
Which measures really work and why
The measures with the best evidence for weight during menopause have one thing in common: They improve metabolic efficiency and insulin sensitivity, rather than just reducing calorie intake.
Strength training is the best supported. It builds and maintains muscle mass. Muscle is the most important site of insulin-mediated glucose uptake and at the same time the tissue that is most directly affected by the decline in NAD⁺ and menopausal muscle loss.
Adequate protein, about 1.6 to 2 grams per kilogram of body weight daily, supports muscle maintenance and produces a lower insulin response than a carbohydrate-rich diet.
Regular endurance exercise improves mitochondrial function and insulin sensitivity over time.
These measures work because they address the metabolic mechanism and not just the calorie balance.
The restoration of NAD⁺ through NMN works with them because it improves the cellular conditions under which they can work at all. Better mitochondrial function means that strength training triggers a stronger metabolic adaptation. Better insulin sensitivity means that the same dietary choices lead to less fat storage.
Research does not support using NMN instead of these fundamentals. It supports using it complementarily to restore the cellular environment in which these fundamentals work as they should.
What is realistically to expect
Weight loss is slower during menopause than in younger years. And returning to pre-menopausal weight is often less realistic and less meaningful as a goal than better metabolic health, better body composition, and more physical performance.
The decisive measure is not the scale. It is the development of visceral fat, insulin sensitivity, and physical resilience over months.
Women who combine strength training, adequate protein, good sleep, and the restoration of NAD⁺ report consistently: The resistance lets up over time and the body responds to exertion again as it used to.
This is not a dramatic transformation. It is a metabolic environment that is shifting back to a functioning state. And that is exactly what the biology of NAD⁺ restoration in postmenopausal women leads one to expect.
Weight gain during menopause has concrete biological causes. And for these causes, there are concrete measures. Women who address the causes directly achieve results that are missed with general dietary advice. The difference is not in discipline. It lies in understanding the problem before trying to solve it.
Sources
- Yoshino, M., Yoshino, J., Kayser, B. D., et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224–1229. https://doi.org/10.1126/science.abe9985
- Liao, B., Zhao, Y., Wang, D., et al. (2021). NMN supplementation enhances aerobic capacity in amateur runners. JISSN, 18(1), 54. https://doi.org/10.1186/s12970-021-00442-4
- Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22(2), 119–141. https://doi.org/10.1038/s41580-020-00313-x
- Massudi, H., Grant, R., Braidy, N., et al. (2012). Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLOS ONE, 7(7), e42357. https://doi.org/10.1371/journal.pone.0042357
- Imai, S. I., & Guarente, L. (2014). NAD+ and sirtuins in aging and disease. Trends in Cell Biology, 24(8), 464–471. https://doi.org/10.1016/j.tcb.2014.04.002
- Kim, M., Seol, J., Sato, T., et al. (2022). Effect of 12-week intake of NMN on sleep quality, fatigue, and physical performance. Nutrients, 14(4), 755. https://doi.org/10.3390/nu14040755
